These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 35536283)

  • 21. Influence of age, gender, previous SARS-CoV-2 infection, and pre-existing diseases in antibody response after COVID-19 vaccination: A review.
    Fernandes MDCR; Vasconcelos GS; de Melo ACL; Matsui TC; Caetano LF; de Carvalho Araújo FM; Fonseca MHG
    Mol Immunol; 2023 Apr; 156():148-155. PubMed ID: 36921489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can Individuals with Suboptimal Antibody Responses to Conventional Antiviral Vaccines Acquire Adequate Antibodies from SARS-CoV-2 mRNA Vaccination?
    Ogura W; Ohtsuka K; Matsuura S; Okuyama T; Matsushima S; Yamasaki S; Miyagi H; Sekiguchi K; Ohnishi H; Watanabe T
    Viruses; 2022 May; 14(5):. PubMed ID: 35632698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination: A Prospective Cohort Study.
    Olmstead AD; Nikiforuk AM; Schwartz S; Márquez AC; Valadbeigy T; Flores E; Saran M; Goldfarb DM; Hayden A; Masud S; Russell SL; Prystajecky N; Jassem AN; Morshed M; Sekirov I
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia.
    Parry H; McIlroy G; Bruton R; Damery S; Tyson G; Logan N; Davis C; Willett B; Zuo J; Ali M; Kaur M; Stephens C; Brant D; Otter A; McSkeane T; Rolfe H; Faustini S; Richter A; Lee S; Wandroo F; Shafeek S; Pratt G; Paneesha S; Moss P
    J Hematol Oncol; 2022 Jan; 15(1):3. PubMed ID: 35000597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 Vaccination IgG Antibody Responses in Patients with Hematologic Malignancies in a Myeloid Enriched Cohort: A Single Center Observation.
    Hoff FW; Goksu SY; Premnath N; Patel PA; Ikpefan R; Kaur G; Vusirikala M; Bat T; Chen W; Geethakumari PR; Anderson LD; Awan FT; Collins RH; Weinberg OK; Muthukumar A; Chung SS; Madanat YF
    Acta Med Acad; 2023 Apr; 52(1):30-36. PubMed ID: 37326395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The third inactivated vaccine booster dramatically enhanced SARS-CoV-2 antibody responses and did not influence the profile of prothrombotic antibody.
    Pan Y; Wang S; Liu G; Wang L; Yang L; Zeng X; Qian C; Lin J; Pan Z; Li Y
    J Med Virol; 2023 Jan; 95(1):e28356. PubMed ID: 36443279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia.
    Tiacci E; Mancini A; Marchetti M; D'Elia GM; Candoni A; Morotti A; Romano A; Gozzetti A; Broccoli A; De Carolis L; Bruna R; Tisi MC; Selleri C; Capponi M; Vallisa D; Cattaneo C; Della Porta MG; Busca A; Falini B; Massaia M; Bertù L; Pulsoni A; Rivela P; Corradini P; Passamonti F
    Br J Haematol; 2023 May; 201(3):411-416. PubMed ID: 36541031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamics of SARS-CoV-2 Antibody Responses up to 9 Months Post-Vaccination in Individuals with Previous SARS-CoV-2 Infection Receiving Inactivated Vaccines.
    Wang J; Huang L; Guo N; Yao YP; Zhang C; Xu R; Jiao YM; Li YQ; Song YR; Wang FS; Fan X
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37112897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody response to COVID-19 vaccination in patients with lymphoma.
    Narita K; Nakaji S; Tabata R; Terao T; Kuzume A; Tsushima T; Ikeda D; Fukumoto A; Miura D; Takeuchi M; Doi M; Umezawa Y; Otsuka Y; Takamatsu H; Matsue K
    Int J Hematol; 2022 May; 115(5):728-736. PubMed ID: 35188650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of anti-SARS-CoV-2 IgG and IgA antibody responses post complete vaccination, 7 months later and after 3rd dose of the BNT162b2 vaccine in healthy adults.
    Rastawicki W; Juszczyk G; Gierczyński R; Zasada AA
    J Clin Virol; 2022 Jul; 152():105193. PubMed ID: 35660747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of serological response to anti-SARS-CoV-2 mRNA vaccination in hematological patients.
    Pascale SP; Nuccorini R; Pierri T; Di Mare R; Fabio L; Lerose E; Merlino MA; Schiavo P; Amendola A; Brucoli G; Caputo MD; Chitarrelli I; Cimminiello M; Coluzzi S; Filardi NB; Matturro A; Vertone D; Poggiaspalla M; Malaspina F; Musuraca G; Coralluzzo G; Mannarella C; Musto C; Bellettieri AP; Martinelli G; Cerchione C; Pizzuti M
    Front Immunol; 2022; 13():892331. PubMed ID: 36003404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody response to SARS-CoV-2 vaccines in patients with relapsing multiple sclerosis treated with evobrutinib: A Bruton's tyrosine kinase inhibitor.
    Bar-Or A; Cross AH; Cunningham AL; Hyvert Y; Seitzinger A; Gühring H; Drouin EE; Alexandri N; Tomic D; Montalban X
    Mult Scler; 2023 Oct; 29(11-12):1471-1481. PubMed ID: 37626477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased Antibody Response After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Patients With Down Syndrome.
    Streng BMM; Bont M; Delemarre EM; Binnendijk RS; Smit G; den Hartog G; Coppus AMW; de Vries E; Weijerman ME; Lamberts R; de Graaf G; van der Klis FR; Vidarsson G; Rave N; Bont LJ; Wildenbeest JG
    J Infect Dis; 2022 Sep; 226(4):673-677. PubMed ID: 35748853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273.
    Steensels D; Pierlet N; Penders J; Mesotten D; Heylen L
    JAMA; 2021 Oct; 326(15):1533-1535. PubMed ID: 34459863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant.
    Valanparambil RM; Carlisle J; Linderman SL; Akthar A; Millett RL; Lai L; Chang A; McCook-Veal AA; Switchenko J; Nasti TH; Saini M; Wieland A; Manning KE; Ellis M; Moore KM; Foster SL; Floyd K; Davis-Gardner ME; Edara VV; Patel M; Steur C; Nooka AK; Green F; Johns MA; O'Brein F; Shanmugasundaram U; Zarnitsyna VI; Ahmed H; Nyhoff LE; Mantus G; Garett M; Edupuganti S; Behra M; Antia R; Wrammert J; Suthar MS; Dhodapkar MV; Ramalingam S; Ahmed R
    J Clin Oncol; 2022 Nov; 40(33):3808-3816. PubMed ID: 35759727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers.
    Laing ED; Weiss CD; Samuels EC; Coggins SA; Wang W; Wang R; Vassell R; Sterling SL; Tso MS; Conner T; Goguet E; Moser M; Jackson-Thompson BM; Illinik L; Davies J; Ortega O; Parmelee E; Hollis-Perry M; Maiolatesi SE; Wang G; Ramsey KF; Reyes AE; Alcorta Y; Wong MA; Lindrose AR; Duplessis CA; Tribble DR; Malloy AMW; Burgess TH; Pollett SD; Olsen CH; Broder CC; Mitre E
    Emerg Infect Dis; 2022 Apr; 28(4):828-832. PubMed ID: 35203111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody Responses to SARS-CoV-2 After Infection or Vaccination in Children and Young Adults With Inflammatory Bowel Disease.
    Dailey J; Kozhaya L; Dogan M; Hopkins D; Lapin B; Herbst K; Brimacombe M; Grandonico K; Karabacak F; Schreiber J; Liang BT; Salazar JC; Unutmaz D; Hyams JS
    Inflamm Bowel Dis; 2022 Jul; 28(7):1019-1026. PubMed ID: 34528661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 vaccination induces mucosal antibody responses in previously infected individuals.
    Sano K; Bhavsar D; Singh G; Floda D; Srivastava K; Gleason C; ; Carreño JM; Simon V; Krammer F
    Nat Commun; 2022 Sep; 13(1):5135. PubMed ID: 36050304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-S1/RBD-Specific Antibody Formation After SARS-CoV-2 Vaccination in Elderly Rheumatoid Arthritis Patients: Single-Center Prospective Observational Study.
    Kang ES; Oh JS; Lee EJ; Hong S; Ahn SM; Lee CK; Yoo B; Kim YG
    J Korean Med Sci; 2023 Apr; 38(14):e109. PubMed ID: 37038645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody response to SARS-CoV-2 vaccination or infection in a prospective cohort of children with neuroinflammatory diseases.
    Kaufmann C; Morris M; Gombolay GY
    Eur J Paediatr Neurol; 2023 Sep; 46():30-34. PubMed ID: 37399703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.